Objective: To obtain estimates ofthe relative efficacy of3 main treatment strategies for attention-deficit hyperactivity disorder (ADHD) in children and youth (age < 18 years).
A ttention-deficit hyperactivity dis~rder .(ADH~) is the most frequently diagnosed behaviour disorder In North American children (1) and the most abundantly researched in child psychiatry (2, 3) . This disorder consists of a combination ofbehavioural features, including developmentally inappropriate levels of inattentiveness to task, distractibility, impulsiveness, and motor overactivity (4, 5) . ADHD is strongly associated with poor academic performance; a pattern of conflictual and often unsatisfactory relations with peers, family members, and teachers; and low self-esteem.
Though psychostimulant drugs have been known for many years to be useful in the management ofADHD (6) , concerns have been expressed in the popular media and the medical-scientific community over the rising number of prescriptions for psychostimulants and about possible overdiagnosis ofADHD (7, 8) . Whereas the diagnosis is less often made and medication less frequently prescribed in Europe and Australia (9) (10) (11) , in North America an estimated 3% to 5% of school-aged children meet the diagnostic criteria set out in the Diagnostic and Statistical Manual for Mental Disorders (DSM-IV) (3) . Adding to the controversy are questions about the safety of individual patients (for example, the possibility of adverse effects), the potential for illicit use and abuse of psychostimulants, the economic impact of increasing prescriptions, and the relative effectiveness and safety of nondrug interventions.
This quantitative review estimates the relative efficacy ofdifferent management strategies for ADHD. Current strategies broadly consist of medicating the child to reduce the frequency and intensity of problematic behaviours and to allow the child to achieve better self-control and betterregulation of attention to task; educating parents and teachers about the nature ofADHD, thereby allowing them to have realistic expectations of the child, providing them with simple strategies to modify the child's environment to reduce behaviour problems, and training them to acquire effective behaviour-management skills; and using psychological therapy to teach the child self-control and self-monitoring skills. Ideally, a review of treatment efficacy in ADHD would consider outcomes that relate to the whole array ofproblems with which these children present, including behavioural, academic, and social-emotional problems. However, multiple sources ofheterogeneity among patients, treatments, and outcomes in published studies of ADHD pose significant challenges to interpreting research findings (12, 13) .
To reduce heterogeneity and make our efficacy evaluation as generalizable as possible, we restricted our review to studies ofchildren and youth who are broadly representative ofthose with ADHD (rather than diagnostic subgroups), who are treated and monitored for effects in naturalistic settings (such as home and school rather than laboratory-based settings), and for whom treatment efficacy is demonstrated by differences in scores on common teacher-and parent-completed behaviour rating scales designed to assess both core and associated features of ADHD.
Methods

Search Strategy
The following electronic databases were searched duringAugust 1997: Current Index to Journals in Education (CIJE), Healthstar, Medline, and Psycinfo (1981 onward); Embase (1988 onward); First Search (Article First) (from 1990); and Current Contents (1995 onward). Search terms included "attention deficit disorder" (ADD), "attention deficit disorder with hyperactivity" (ADD-H), "attention-deficit hyperactivity disorder," "hyperkinetic disorder," and "hyperkinesis." Search terms for drug-treatment interventions included: "methylphenidate" (MPH), "dextroamphetamine" (DAS), "pemoline," "central nervous system stimulants," "psychostirnulants," and the brand names "Ritalin," "Dexedrine," and "Cylert." Search terms for nondrug interventions included: "counselling," "psychotherapy," "cognitive therapy," "cognitive-behavioural therapy," "parent training," "family therapy," "family counselling," "behaviour therapy," "behaviour modification," "biofeedback," "neurofeedback," and "relaxation therapy." In addition, the Cochrane Database was checked for completed or ongoing reviews; bibliographic lists from key textbooks (2, 9, (14) (15) (16) ) and reviews published in major journals (17) (18) (19) (20) (21) (dated 1995 or later) were handsearched; and trial information was requested from the following drug manufacturers: Novartis, SmithKline Beecham, and Abbott.
Inclusion Criteria
Trials were eligible for inclusion ifthey met the following criteria: random assignment of subjects to treatment conditions; publication date of 1981 or later, having adopted DSM-III's more detailed and stringent diagnostic criteria; subjects aged 0-18 years with a diagnosis of ADD, ADD-H, or ADHD made in an explicit and reproducible way and no coexisting diagnoses; effects of at least 1 week of stimulant medication (that is, MPH, DAS, or pemoline) administered on consecutive days or the effects of a course of psychosocial interventi o n: and outcome measured with a teacher-or , parent-completed behaviour rating scale and in a form suitable for metaanalysis.
Titles or abstracts of all potentially eligible studies were reviewed against these criteria. Possible or definitely eligible studies were retrieved and reviewed in detail by 2 different reviewers, with disagreements settled by consensus.
Methodological Quality
Methodological quality was assessed by 2 reviewers using the scale developed by Jadad and colleagues (22) , with scoring differences settled by consensus. Items assess randomization, double blinding, and description ofwithdrawals. Scores rangefrom°to 5, with scores less than 3 indicating poor quality.
Data Extraction
Datawere extracted for 6 areas: study characteristics (for example, design); subject characteristics (age and sex); intervention characteristics (details about treatment); subject attrition; adverse treatment reactions; and main outcome measurements. All extracted data for outcome measurements were rechecked against the original articles at the time ofdata entry.
Medication studies varied in expressing dosage in absolute terms (that is, total mg ofdrug) or relative to body weight (that is, mg/kg) and using single or multiple dose levels. We adopted mg/kg daily as the standardized unit, using either the average weight ofthe sample or the age and sex ofthe sample combined with normative information on weights supplied by the National Center for Health Statistics to express dose levelsuniformly across studies. We analyzed drug effects for only 1 dose level from each study. For studies that reported effects of multiple dose levels, this necessitated selecting 1 dose level. We computed the average dose reported in single-dose studies of MPH (0.7 mg/kg daily) and used this value to guide data extraction from multiple-dose studies. Since the "most equivalent dose" to the average MPH dose in the single study of pemoline effects was between 75 mg and 37.5 mg, we extracted outcome data related to the lower dose to avoid inflating a possible drug effect.
Behaviour rating scales are widely used and of established value both clinically, to aid in diagnosis and monitor treatment effects, and in research applications with ADHD children (5, 23, 24) . Of the many scales available, the Hyperactivity Index of Conners' Teacher Rating Scale and Conners' Parent Rating Scale, also known as the Abbreviated Symptom Questionnaire or Abbreviated Conners' TeacherlParent Rating Scales, are perhaps the most widely used measures of treatment effects in ADHD. These instruments assess the cluster ofcore ADHD symptoms and associated features that contribute to various social and academic problems. We compiled a list of the more frequently used behaviour rating scales, similar conceptually and psychometrically to the Conners scales, and organized them hierarchically into algorithmic charts (1 each for teacher and parent scales) based on their characteristics, including their overall similarity of aim to the Conners scales, and their relative frequency of use. The utility, standardization, and psychometric properties of the instruments fmally selected for use have been reported and reviewed elsewhere (5, (23) (24) (25) . Outcome data were extracted for 1 teacher and I parent behaviour rating scale according to the order given in the algorithmic charts.
Four instruments provide separate scores for different subscales. For the AD D-H: Comprehensive Teacher's Rating Scale (ACTeRS), it is not appropriate to produce a total score from the subscales, so extracted data refer to the attention subscale. For the other instruments, subscale scores were combined. Data presented separately by mutually exclusive subgroups were also combined for each instrument (for example, low-, average-, and high-weight subjects were combined). Extracted data refer to the first posttreatment assessment, since not all studies provided further follow-up data. We ensured that data from the individual studies were presented in comparable units of measurement.
Statistical Analysis
RevMan 3.0 software (26) and the DerSimonian and Laird method were used to calculate either a weighted mean difference (WMD) or standardized mean difference (SMD) for each outcome, depending on whether 1 or more than 1behaviour rating scale was used to measure the outcome across the studies. A random-effects model was used because ofheterogeneity across a range ofvariables (for example, intervention, drug dose, timing of follow-up, outcome measures, and sample size). The stimulant drugs, considered a class of medication with similar effects by authoritative reviews of ADHD pharmacotherapy (9, 11, 21, 27) , were analyzed collectively. Data from 2 parallel-group trials were included with the crossover studies in the analysis of medication-only effects.
Results
Search Findings
The initial search yielded over 1000 citations. Of these, 195 treatment studies were examined in detail; 26 met the study inclusion criteria .
Quality Scores
The majority ofstudies (n = 17) had reasonably good methodological quality (that is, a score of 3 or more) (Table 1) . Twenty-two studies were described as randomized (29-42, 44-46,48-51,26 ), 22 as double-blind (28) (29) (30) 32, 33, (35) (36) (37) (38) (39) (41) (42) (43) (45) (46) (47) (48) (49) (50) (51) (52) (53) , and 13 provided a statement on withdrawals (31, (35) (36) (37) (40) (41) (42) (44) (45) (46) (49) (50) (51) .
Study Characteristics
Characteristics of the 26 studies are given in Table 1 . Twenty-four studies involved the use of medication. Nineteen studies, all drug-treatment studies, used a crossover design and a between-subjects parallel design was used in 7 studies. Data were extracted for 5 teacher-and 4 parent-completed behaviour rating scales.
Subject Characteristics
Subjects were diagnosed as having ADD, ADD-H, or ADHD using DSM-III criteria in 14 studies (28) (29) (30) 32, 33, 36, 38, 41, 43, 45, 47, 49, 52, 53) , DSM-III-R criteria in 8 studies (35, 37, 39, 40, 46, 48, 50, 51) or a combination ofclinical evaluation and a clinically significant score on a behaviour rating scale in 4 studies (31, 34, 42, 44) . Eleven studies reported the presence of a comorbid condition, most frequently conduct disorder (28) Arnold and others (29) Barkley and others (30) Bloomquist and others (31) Brown and Sexson (32) Brown and others (33) Brown and others (34) Buitelaar and others (35) Donnelly and others (36) DuPaul and others (37) DuPaul and Rapport (38) Evans and Pelham (39) Fehlings and others (40) Firestone and others (41) Fischer and Newby (42) Fitzpatrick and others (43) KJonnan and others (44) McBride and others (45) M usten and others (46) Pelham and others (47) Rapport and others (48) Rapport and others (49) Schachar and others (50) Stein and others (51) Tirosh and others (52) Zametkin and others (53) (32, 33, 35, 39, 43, 46, 50, 51, 53) and oppositional defiant disorder (31, 39, 43, 44, 46, 50, 51) . Reasons for sample attrition were mentioned in 10 studies (31,33,36,41,42,44---46,50,51) , with the percentage of participants lost ranging from 4% to 78%.
Intervention Characteristics
Details about the interventions in the medication-only studies appear in Table 2 and for the 2 behavioural studies and 3 combination studies in Table 3 . Adverse reactions to MPH resulted in 6 subjects dropping out of2 different studies (50, 51) .
Estimation of Treatment Efficacy
Figures 1 and 2 display the relative efficacy of medication, behavioural therapy, and combined therapies for teacher-and parent-completed measures sorted by effect size.
Significant treatment effects attributable to medication-only therapy were found for both teacher-and parent-completed outcome measures. No overall differences in efficacy were found when medication-only studies with poor quality scores were compared with studies with scores of 3 and above for both teacher and parent outcome measures. Two studies provided data about the efficacy of behavioural treatments used alone. Significant effects were not found on teacher or parent ratings of behaviour for treatment "packages" in relation to control subjects or comparison groups. Three studies provided data about combined modalities of treatment, which permitted 3 kinds of comparison to be made. Combination therapy was found to be more efficacious than placebo or no treatment for parent but not teacher ratings, not more efficacious than drug therapy alone, and more efficacious than limited pool of 3 studies, all of which used small samples (average of 15 subjects), and differed in terms of methodological quality, treatments provided, comparison or control groups used, and follow-up arrangements. Further, for some analyses performed, results were discrepant between studies. Since drug therapy alone was found to be efficacious, we might expect the combination of drug therapy plus another modality oftherapy also to be efficacious, compared with either no therapy or placebo or behavioural therapies used alone. However, present results only minimally support this expectation. Such discrepancies are also found in the broader published literature examining the efficacy of combined modalities of therapy (59,63-68). While the effects of stimulant medications lend themselves well to highly controlled experimental studies, behavioural treatments are harder to evaluate in this way. Children with ADHD are heterogeneous with respect to the problems they present to clinicians (and to parents, teachers, and peers) as well as in their needs. The research literature, however, has assembled cohorts of ADHD cases by convenience and provides a predetermined package of therapy or therapies without regard for individual needs and differences. In such situations we expect to find within-subject research designs, which control for individual differences, to show larger effects, a tendency described by others (54, 69) . In the present study, this mechanism could explain, at least in part, the strong evidence of efficacy for medication-only studies and the weak and inconsistent findings for other kinds of interventions. Though we combined data to increase the cumulative numbers of treated and control subjects, a prime purpose of metaanalysis, sample size for studies of nonmedical and combination therapy remained small, so failure to find significant results may reflect a Type II error.
It is possible that medication may be most efficacious at reducing the "core" symptoms of ADHD, while behavioural therapies may be most efficacious at reducing associated features (for example, conflictual relationships with peers and poor academic performance). The latter effects may show up more on other kinds of measures, such as direct observations ofthe student or measures of individual achievement. We did not estimate efficacy in these associated domains because only some studies included them and because of the wide range of measures that would need combining. Hence, this (29) Barkley and others (30) Brown and Sexson (32) Buitelaar and others (35) Donnelly and others (36) DuPaul and others (37) DuPaul and Rapport (38) Evans and Pelham (39) Fischer and Newby (42) Fitzpatrick and others (43) Klorman and others (44) McBride and others (45) Musten and others (46) Pelham and others (47) Rapport and others (48) Rapport and others (49) Schachar and others (50) Stein and others (51 ) Tirosh and others (52) Zametkin and others (53) Author DAS = dextroamphetamine; MPH = methylphenidate.
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Discussion
Medication therapy was efficacious in reducing elevated levels of behaviours (symptoms) measured by changes within individual subjects within weeks oftreatment onset and while continuing to take medication. These findings agree with those widely reported in primary treatment studies, authoritative overviews (2,9,14--21) , previous metaanalyses (54--56) , and practice guidelines published in the medical literature (18) .
The behavioural therapies failed to produce significant differences in ADHD symptomatology on teacher or parent measures between groups. However, only 2 studies were analyzed in this category, each with very small samples (n < 13 in all experimental arms) and poor methodological quality, and these studies differed in their findings (one found a significant effect of treatment while the other did not). The 2 studies also differed in terms of the interventions provided and the selection and management ofcontrol subjects and follow-up as well as in the outcome measures used. These results need to be viewed alongside others in the published literature (57) (58) (59) (60) (61) (62) , which also provides mixed or conflicting evidence of the efficacy of behavioural therapies used alone.
For combination therapy, the analyses done to contrast various treatment conditions combined data derived from a Brown and
Children referred to project were Children referred to the project Child (treatment) = 24 x 60-minute individual Not described Pretest others (34) randomized to 1 of 3 treatment were randomized to I of 3 sessionss over 3 months 3 month groups. Assignment to treatment groups. Assignment Parent and teacher (treatment) = consultation 6 month comparison group not random, to comparison group not sessions on applying training strategies (amount as subjects recruited from a random, as subjects recruited not described) waiting list. study's exclusive focus on behaviour rating scales may have introduced a bias in favour of medication over behavioural therapies. Future research will need to identify the best outcome measures for evaluating nonmedication therapies.
Conclusion
Though our results suggest that medical therapy is efficacious in managing children with ADHD, that nonmedical interventions used alone are not efficacious, and that combinations of medical and nonmedical therapies may be efficacious in some situations, a paucity of research evaluating nonmedical and combined modalities of therapy, a lack of good quality experimental research, and a great deal of heterogeneity between studies in choice of subjects, interventions, control subjects, and outcome measures made the results difficult to interpret, since they were combined across studies. These and other pitfalls have led previous reviewers to conclude that: "any attempt to identify the best treatment becomes an empty and futile exercise" (12) . While this may be an overstatement, we believe these factors do limit the applicability of our results to health policy decisions, particularly as regards behavioural and combined forms of therapy. We recommend that caution be exercised in this regard. The relative benefits of different modalities of therapy for ADHD in children will Figure 2 . Summary of standardized mean differences for parent rating scales for 3 main treatment strategies for ADHD need to be revisited as the deficits identified in the published literature are addressed.
